Every weekday for over three decades, Morning Edition has taken listeners around the country and the world with two hours of multi-faceted stories and commentaries that inform, challenge and occasionally amuse.
A highly anticipated study of a COVID-19 vaccine has finally produced results — and the results are good, very good. The vaccine is made by the Maryland biotech company Novavax.